Vir Biotechnology, Inc. (NASDAQ:VIR) Receives $32.86 Average Target Price from Analysts
Shares of Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) have been given an average recommendation of “Moderate Buy” by the seven ratings firms that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average […]
Shares of Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) have been given an average recommendation of “Moderate Buy” by the seven ratings firms that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average […]
